Product NDC: | 66435-410 |
Proprietary Name: | Topotecan Hydrochloride |
Non Proprietary Name: | topotecan hydrochloride |
Active Ingredient(s): | 4 mg/4mL & nbsp; topotecan hydrochloride |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 66435-410 |
Labeler Name: | Three Rivers Pharmaceuticals, LLC. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA091199 |
Marketing Category: | ANDA |
Start Marketing Date: | 20101202 |
Package NDC: | 66435-410-05 |
Package Description: | 5 VIAL, GLASS in 1 CARTON (66435-410-05) > 4 mL in 1 VIAL, GLASS |
NDC Code | 66435-410-05 |
Proprietary Name | Topotecan Hydrochloride |
Package Description | 5 VIAL, GLASS in 1 CARTON (66435-410-05) > 4 mL in 1 VIAL, GLASS |
Product NDC | 66435-410 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | topotecan hydrochloride |
Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20101202 |
Marketing Category Name | ANDA |
Labeler Name | Three Rivers Pharmaceuticals, LLC. |
Substance Name | TOPOTECAN HYDROCHLORIDE |
Strength Number | 4 |
Strength Unit | mg/4mL |
Pharmaceutical Classes | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] |